Synthesis and estrogenic activity of BODIPY-labeled estradiol conjugates
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
38797442
DOI
10.1016/j.ejps.2024.106813
PII: S0928-0987(24)00125-8
Knihovny.cz E-zdroje
- Klíčová slova
- 17β-estradiol, BODIPY, CuAAC, Estrogenic activity, Human estrogen receptor alpha,
- MeSH
- alfa receptor estrogenů * metabolismus chemie MeSH
- azidy chemie MeSH
- estradiol * chemie farmakologie MeSH
- estrogeny chemie MeSH
- fluorescenční barviva chemie MeSH
- lidé MeSH
- MFC-7 buňky MeSH
- nádorové buněčné linie MeSH
- proliferace buněk účinky léků MeSH
- simulace molekulového dockingu * MeSH
- sloučeniny boru * chemie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene MeSH Prohlížeč
- alfa receptor estrogenů * MeSH
- azidy MeSH
- ESR1 protein, human MeSH Prohlížeč
- estradiol * MeSH
- estrogeny MeSH
- fluorescenční barviva MeSH
- sloučeniny boru * MeSH
Novel BODIPY-estradiol conjugates have been synthesized by selecting position C-3-O for labeling. The conjugation strategy was based on Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) or etherification. Estradiol derivatives used as azide partners bearing an ω-azidoalkyl function through C4-C8-long linkers have been prepared. CuAAC reactions of estradiol azides with BODIPY alkyne furnished fluorescent 3-O-labeled conjugates bearing the triazole ring as a coupling moiety. Williamson etherifications of 3-O-(ω-bromoalkyl)-17β-estradiol derivatives with BODIPY-OH resulted in labeled conjugates connected with an ether moiety. Interactions of the conjugates with estrogen receptor (ER) were investigated using molecular docking calculations in comparison with estradiol. The conjugates occupied both the classical and alternative binding sites on human ERα, with slightly lower binding affinity to references estradiol and diethystilbestrol. All compounds have displayed reasonable estrogenic activity. They increased the proliferation of ER-positive breast cancer cell line MCF7 contrary to ER-negative SKBR-3 cell line. The most potent compound 13a induced the transcriptional activity of ER in dose-dependent manner in dual luciferase recombinant reporter model and increased progesterone receptor's expression, proving the retained estrogenic activity. The fluorescence of candidate compound 13a co-localised with the ERα. The newly synthesized labeled compounds might serve as good starting point for further development of fluorescent probes for modern biological applications. In addition to studying steroid uptake and transport in cells, e.g. in the processes of biodegradation of estrogen-hormones micropollutants, they could also be utilized in examination of estrogen-binding proteins.
Citace poskytuje Crossref.org